SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001396814-24-000117
Filing Date
2024-08-19
Accepted
2024-08-19 08:25:46
Documents
1
Period of Report
2024-08-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1724070340.html 4  
1 FORM 4 wk-form4_1724070340.xml 4 3020
  Complete submission text file 0001396814-24-000117.txt   4795
Mailing Address C/O ONYX PHARMACEUTICALS, INC. 2100 POWELL STREET EMERYVILLE CA 94608
Business Address
Brege Laura (Reporting) CIK: 0001365619 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35060 | Film No.: 241218316

Mailing Address 5401 WEST KENNEDY BOULEVARD SUITE 890 TAMPA FL 33609
Business Address 5401 WEST KENNEDY BOULEVARD SUITE 890 TAMPA FL 33609 813-553-6680
Pacira BioSciences, Inc. (Issuer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)